1-6 of 6
Keiko Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3961: Cancer stem cells, not bulk tumor cells, predict mechanisms of resistance to SMO inhibitors in SHH medulloblastoma

Joshy George, Yaohui Chen, Nourhan Abdelfattah, Keiko Yamamoto, Scott Adamson, Jong Min Choi, Brad Rybinski, Anuj Srivastava, Parveen Kumar, Min Gyu Lee, David S. Baskin, Wen Jiang, Betty Y. Kim, William Flavahan, Jeffrey H. Chuang, Sung Yun Jung, Kyuson Yun
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3961.
https://doi.org/10.1158/1538-7445.AM2022-3961
Published: 15 June 2022
View article titled, Abstract 3961: Cancer stem cells, not bulk tumor cells, predict mechanisms of resistance to SMO inhibitors in SHH medulloblastoma
Journal Articles

Abstract 165: Cancer stem cell phenotypes determine mechanisms of resistance to targeted therapies

Joshy George, Yaohui Chen, Keiko Yamamoto, Scott Adamson, Jeff Chuang, Kyuson Yun
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 165.
https://doi.org/10.1158/1538-7445.AM2018-165
Published: 01 July 2018
View article titled, Abstract 165: Cancer stem cell phenotypes determine mechanisms of resistance to targeted therapies
Journal Articles

S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma

Kin-Hoe Chow, Hee Jung Park, Joshy George, Keiko Yamamoto, Andrew D. Gallup, Joel H. Graber, Yuanxin Chen, Wen Jiang, Dennis A. Steindler, Eric G. Neilson, Betty Y.S. Kim, Kyuson Yun
Journal: Cancer Research
Cancer Res (2017) 77 (19): 5360–5373.
https://doi.org/10.1158/0008-5472.CAN-17-1294
Published: 01 October 2017
View article titled, S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
Open the PDF for S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Expression and Mutational Analysis of the DCC, DPC4, and MADR2/JV18-1 Genes in Neuroblastoma

Xiao-Tang Kong, Seung Hoon Choi, Akira Inoue, Feng Xu, Tao Chen, Junko Takita, Jun Yokota, Fumio Bessho, Masayoshi Yanagisawa, Ryoji Hanada, Keiko Yamamoto, Yasuhide Hayashi
Journal: Cancer Research
Cancer Res (1997) 57 (17): 3772–3778.
Published: 01 September 1997
View article titled, Expression and Mutational Analysis of the <em>DCC, DPC4</em>, and <em>MADR2/JV18-1</em> Genes in Neuroblastoma
Open the PDF for Expression and Mutational Analysis of the <em>DCC, DPC4</em>, and <em>MADR2/JV18-1</em> Genes in Neuroblastoma in another window
Journal Articles

Deletion Map of Chromosome 9 and p16 (CDKN2A) Gene Alterations in Neuroblastoma

Junko Takita, Yasuhide Hayashi, Takashi Kohno, Naohito Yamaguchi, Ryoji Hanada, Keiko Yamamoto, Jun Yokota
Journal: Cancer Research
Cancer Res (1997) 57 (5): 907–912.
Published: 01 March 1997
View article titled, Deletion Map of Chromosome 9 and <em>p16</em> (<em>CDKN2A</em>) Gene Alterations in Neuroblastoma
Open the PDF for Deletion Map of Chromosome 9 and <em>p16</em> (<em>CDKN2A</em>) Gene Alterations in Neuroblastoma in another window
Journal Articles

Mutations of the p53 Gene Are Involved in Ewing's Sarcomas but not in Neuroblastomas

Hiroaki Komuro, Yasuhide Hayashi, Machiko Kawamura, Kenshi Hayashi, Yasuhiko Kaneko, Shigehiko Kamoshita, Ryoji Hanada, Keiko Yamamoto, Teruaki Hongo, Masao Yamada, Yoshiaki Tsuchida
Journal: Cancer Research
Cancer Res (1993) 53 (21): 5284–5288.
Published: 01 November 1993
View article titled, Mutations of the <em>p53</em> Gene Are Involved in Ewing's Sarcomas but not in Neuroblastomas
Open the PDF for Mutations of the <em>p53</em> Gene Are Involved in Ewing's Sarcomas but not in Neuroblastomas in another window